Skip to main content

Soft-tissue Fillers and SARS-CoV-2 Vaccines: Where Do We Stand?

TO REGISTER: Scroll down and select the Webinar component or add to cart
ASDS Fellow Members and Residents: Complimentary
Non-Members: $99

On-demand access to webinar held live on Sunday, January 3, 2021. This one-hour, panel-style webinar addresses the latest news and concerns about soft-tissue fillers and SARS-CoV-2 vaccines. Learn about the FDA’s data on adverse events associated with the mRNA vaccine and discover appropriate treatment protocol, patient consent and communications and implications for your cosmetic practice. CME: 1.00 AMA PRA Category 1 Credit™

ASDS Fellow Members and Residents: Complimentary
Adjunct Members and Non-Member Derms: $99

This webinar was designed to share guidance based on the latest available information. ASDS will make reasonable efforts to provide updates as new information becomes available. This webinar does not constitute legal advice or substitute for individual medical decision-making.

Kavita Mariwalla, MD - ASDS Secretary
Mariwalla Dermatology
West Islip, NY

Mathew Avram, MD, JD - ASDS President
Massachusetts General Hospital Dermatology Laser and Cosmetic Center
Boston, MA

Sue Ellen Cox, MD - ASDS President-Elect
Aesthetic Solutions PA
Chapel Hill, NC

Vince Bertucci, MD, FRCPC - ASDS Vice President
Bertucci Dermatology
Toronto, Ontario

Derek Jones, MD - ASDS Soft Tissue Fillers Guideline Task Force Chair
Skin Care and Laser Physicians of Beverly Hills
West Hollywood, CA

The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.